CAH
Price
$156.60
Change
-$1.64 (-1.04%)
Updated
Aug 6 closing price
Capitalization
27.26B
5 days until earnings call
COR
Price
$283.78
Change
-$8.57 (-2.93%)
Updated
Aug 6 closing price
Capitalization
48.42B
91 days until earnings call
Interact to see
Advertisement

CAH vs COR

Header iconCAH vs COR Comparison
Open Charts CAH vs CORBanner chart's image
Cardinal Health
Price$156.60
Change-$1.64 (-1.04%)
Volume$1.71M
Capitalization27.26B
Cencora
Price$283.78
Change-$8.57 (-2.93%)
Volume$2.38M
Capitalization48.42B
CAH vs COR Comparison Chart in %
Loading...
CAH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CAH vs. COR commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAH is a Hold and COR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (CAH: $156.60 vs. COR: $283.78)
Brand notoriety: CAH and COR are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: CAH: 88% vs. COR: 198%
Market capitalization -- CAH: $27.26B vs. COR: $48.42B
CAH [@Medical Distributors] is valued at $27.26B. COR’s [@Medical Distributors] market capitalization is $48.42B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAH’s FA Score shows that 1 FA rating(s) are green whileCOR’s FA Score has 2 green FA rating(s).

  • CAH’s FA Score: 1 green, 4 red.
  • COR’s FA Score: 2 green, 3 red.
According to our system of comparison, COR is a better buy in the long-term than CAH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAH’s TA Score shows that 1 TA indicator(s) are bullish while COR’s TA Score has 3 bullish TA indicator(s).

  • CAH’s TA Score: 1 bullish, 8 bearish.
  • COR’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, COR is a better buy in the short-term than CAH.

Price Growth

CAH (@Medical Distributors) experienced а -0.82% price change this week, while COR (@Medical Distributors) price change was -2.75% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was -0.72%. For the same industry, the average monthly price growth was +3.84%, and the average quarterly price growth was +2.33%.

Reported Earning Dates

CAH is expected to report earnings on Aug 12, 2025.

COR is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Medical Distributors (-0.72% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COR($48.4B) has a higher market cap than CAH($27.3B). CAH has higher P/E ratio than COR: CAH (44.47) vs COR (26.47). CAH YTD gains are higher at: 33.874 vs. COR (26.833). COR has higher annual earnings (EBITDA): 3.71B vs. CAH (1.89B). CAH has more cash in the bank: 4.59B vs. COR (2.87B). CAH (4.72B) and COR (4.78B) have identical debt. COR has higher revenues than CAH: COR (272B) vs CAH (216B).
CAHCORCAH / COR
Capitalization27.3B48.4B56%
EBITDA1.89B3.71B51%
Gain YTD33.87426.833126%
P/E Ratio44.4726.47168%
Revenue216B272B79%
Total Cash4.59B2.87B160%
Total Debt4.72B4.78B99%
FUNDAMENTALS RATINGS
CAH vs COR: Fundamental Ratings
CAH
COR
OUTLOOK RATING
1..100
5759
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
81
Overvalued
PROFIT vs RISK RATING
1..100
22
SMR RATING
1..100
9911
PRICE GROWTH RATING
1..100
4551
P/E GROWTH RATING
1..100
9237
SEASONALITY SCORE
1..100
6528

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CAH's Valuation (65) in the Medical Distributors industry is in the same range as COR (81) in the Real Estate Investment Trusts industry. This means that CAH’s stock grew similarly to COR’s over the last 12 months.

CAH's Profit vs Risk Rating (2) in the Medical Distributors industry is in the same range as COR (2) in the Real Estate Investment Trusts industry. This means that CAH’s stock grew similarly to COR’s over the last 12 months.

COR's SMR Rating (11) in the Real Estate Investment Trusts industry is significantly better than the same rating for CAH (99) in the Medical Distributors industry. This means that COR’s stock grew significantly faster than CAH’s over the last 12 months.

CAH's Price Growth Rating (45) in the Medical Distributors industry is in the same range as COR (51) in the Real Estate Investment Trusts industry. This means that CAH’s stock grew similarly to COR’s over the last 12 months.

COR's P/E Growth Rating (37) in the Real Estate Investment Trusts industry is somewhat better than the same rating for CAH (92) in the Medical Distributors industry. This means that COR’s stock grew somewhat faster than CAH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CAHCOR
RSI
ODDS (%)
Bearish Trend 7 days ago
62%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
55%
Bullish Trend 1 day ago
57%
Momentum
ODDS (%)
Bearish Trend 1 day ago
45%
Bearish Trend 1 day ago
46%
MACD
ODDS (%)
Bearish Trend 4 days ago
49%
Bearish Trend 1 day ago
40%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
45%
Bearish Trend 1 day ago
40%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
37%
Bearish Trend 1 day ago
39%
Advances
ODDS (%)
Bullish Trend 4 days ago
65%
Bullish Trend 4 days ago
60%
Declines
ODDS (%)
Bearish Trend 1 day ago
45%
Bearish Trend 1 day ago
41%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
67%
Aroon
ODDS (%)
Bearish Trend 1 day ago
52%
Bearish Trend 1 day ago
27%
View a ticker or compare two or three
Interact to see
Advertisement
CAH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
OBTC32.260.36
+1.13%
Osprey Bitcoin Trust
FSEC43.680.02
+0.05%
Fidelity Investment Grade Sec ETF
MTUL34.91N/A
N/A
ETRACS 2x Lvrgd MSCI US Mntm Fctr TR ETN
TRIO63.15N/A
N/A
MC Trio Equity Buffered ETF
BME35.37-0.23
-0.65%
Blackrock Health Sciences Trust

CAH and

Correlation & Price change

A.I.dvisor indicates that over the last year, CAH has been loosely correlated with COR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CAH jumps, then COR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAH
1D Price
Change %
CAH100%
-1.04%
COR - CAH
56%
Loosely correlated
-2.93%
MCK - CAH
52%
Loosely correlated
-0.81%
YI - CAH
14%
Poorly correlated
-1.60%
HSIC - CAH
14%
Poorly correlated
+2.29%
OMI - CAH
12%
Poorly correlated
-1.23%
More

COR and

Correlation & Price change

A.I.dvisor indicates that over the last year, COR has been loosely correlated with MCK. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if COR jumps, then MCK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COR
1D Price
Change %
COR100%
-2.93%
MCK - COR
66%
Loosely correlated
-0.81%
CAH - COR
51%
Loosely correlated
-1.04%
OMI - COR
20%
Poorly correlated
-1.23%
SHTDF - COR
17%
Poorly correlated
N/A
EDAP - COR
12%
Poorly correlated
-1.57%
More